Crossmark

Piperacillin/tazobactam vs. cefepime or carbapenems for the treatment of bloodstream infections due to bacteria producing chromosomal AmpC beta-lactamase: a systematic review and meta-analysis

Crossref DOI link: https://doi.org/10.1007/s15010-024-02447-y

Published Online: 2024-12-04

Published Print: 2025-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Onorato, Lorenzo

de Luca, Ilaria

Salvati, Annabella

Monari, Caterina

Coppola, Nicola
License Information

Text and Data Mining valid from 2024-12-04

Version of Record valid from 2024-12-04
More Information

Article History

Received: 29 September 2024

Accepted: 26 November 2024

First Online: 4 December 2024

Declarations

:

: The authors declare no competing interests.

: The authors declare that they have no conflicts of interest.

Document is current

Any future updates will be listed below